Comparison Between Adalimumab and Infliximab in Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis

Background and Aims: Anti–tumor necrosis factor therapy has been a mainstay of medical management of perianal Crohn’s disease (CD). This systematic review and meta-analysis aimed to compare the efficacy of adalimumab (ADA) and infliximab (IFX) for the treatment of perianal fistulizing CD. Methods: W...

詳細記述

書誌詳細
出版年:Gastro Hep Advances
主要な著者: Tarek Aboursheid, Azizullah Beran, Mohamad Hijazi, Mhd Kutaiba Albuni, Bisher Sawaf, John J. Guardiola, Khaled Abdeljawad, Benjamin D. McDonald, David T. Rubin
フォーマット: 論文
言語:英語
出版事項: Elsevier 2025-01-01
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S2772572325000846

類似資料